×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PACB – pacific biosciences of california, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PACB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
11:20 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $3.00 price target on the stock.
Low
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $3.00 price target on the stock.
4/9
09:54 am
pacb
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million [Yahoo! Finance]
Medium
Report
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million [Yahoo! Finance]
4/9
09:05 am
pacb
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
High
Report
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
4/4
07:45 pm
pacb
PacBio Grants Equity Incentive Award to New Employee
High
Report
PacBio Grants Equity Incentive Award to New Employee
3/27
09:05 am
pacb
Jim Gibson to join PacBio as Chief Financial Officer
Medium
Report
Jim Gibson to join PacBio as Chief Financial Officer
3/25
10:47 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $6.00 to $2.00. They now have a "sector outperform" rating on the stock.
Neutral
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $6.00 to $2.00. They now have a "sector outperform" rating on the stock.
3/20
11:23 pm
pacb
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
Medium
Report
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
3/17
09:05 am
pacb
Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes
Neutral
Report
Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes
Date
Time
Symbol
Company Name
Action
%Chg
2/13/2025
04:05 pm
PACB
pacific biosciences of california, inc.
IN-LINE
Report
24.2%
pacific biosciences of california, inc.
2/13/2025
04:05 pm
PACB
pacific biosciences of california, inc.
IN-LINE
Report
24.2%
pacific biosciences of california, inc.
2/13/2025
04:05 pm
PACB
pacific biosciences of california, inc.
IN-LINE
Report
24.2%
pacific biosciences of california, inc.
2/13/2025
04:05 pm
PACB
pacific biosciences of california, inc.
IN-LINE
Report
24.2%
pacific biosciences of california, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
09:37 am
pacb
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock, Inc.
4/9
04:09 pm
pacb
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: MILLENNIUM MANAGEMENT LLC
Medium
Report
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: MILLENNIUM MANAGEMENT LLC
4/9
09:09 am
pacb
Form 8-K PACIFIC BIOSCIENCES OF For: Apr 09
Medium
Report
Form 8-K PACIFIC BIOSCIENCES OF For: Apr 09
4/2
04:18 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Mar 31 Filed by: Gibson James R II
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Mar 31 Filed by: Gibson James R II
4/2
04:09 pm
pacb
Form 3 PACIFIC BIOSCIENCES OF For: Mar 31 Filed by: Gibson James R II
Medium
Report
Form 3 PACIFIC BIOSCIENCES OF For: Mar 31 Filed by: Gibson James R II
3/27
09:08 am
pacb
Form 8-K PACIFIC BIOSCIENCES OF For: Mar 24
Medium
Report
Form 8-K PACIFIC BIOSCIENCES OF For: Mar 24
3/21
04:56 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Mar 19 Filed by: Farmer Michele
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Mar 19 Filed by: Farmer Michele
3/21
04:54 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Mar 19 Filed by: Van Oene Mark
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Mar 19 Filed by: Van Oene Mark
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Pacific Biosciences down 19% after patent ruling [Seeking Alpha]
14.8%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
TOP News Decliners
2/6
Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
-11.6%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: